Hormone linked to immune suppression may improve cancer immunotherapy
Researchers at UT Southwestern discovered that a hormone called SCG2 interacts with the receptor LILRB4 on immune cells, suppressing their ability to fight cancer. Blocking this interaction in mice slowed tumor growth, suggesting a new potential target for cancer immunotherapy, while enhancing it could help treat inflammatory disorders.